Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (161-170 of 418) with videos related to

Pageof 42
Sort By:
Dermatology and Therapy|April 4, 2020
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available EvidenceJashin J Wu, Joseph F Merola, Steven R Feldman, et al.
American Journal of Clinical Dermatology|December 21, 2017
Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise UpdateShamir Geller, Haoming Xu, Mark Lebwohl, et al.
Nutrition and Cancer|April 17, 2004
Protective effects of lycopene against ultraviolet B-induced photodamageZsuzsanna Fazekas, Dayuan Gao, Rao N Saladi, et al.
JAMA Dermatology|February 15, 2013
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligoPearl E Grimes, Iltefat Hamzavi, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|July 27, 2025
Healthcare resource utilization and economic burden in generalized pustular psoriasis (GPP) among U.S. adults: A large claims database analysisMark Lebwohl, Bhargav Lakshminarasimhan, Layla Lavasani, et al.
Skinmed|May 23, 2017
Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled StudiesAlan Menter, Linda Stein Gold, John Koo, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment|April 26, 2021
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasisMark Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Cutis|March 22, 2011
Necrolytic migratory erythema associated with a metastatic neuroendocrine tumorMargarita S Lolis, Anna Krishtul, Claudia Vidal, et al.
Journal of the American Academy of Dermatology|December 31, 2005
The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasisAlan Menter, Jennifer C Cather, Diane Baker, et al.
Pageof 42

Showing results (161-170 of 418) with videos related to

Sort By:
Pageof 42
Dermatology and Therapy|April 4, 2020
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available EvidenceJashin J Wu, Joseph F Merola, Steven R Feldman, et al.
American Journal of Clinical Dermatology|December 21, 2017
Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise UpdateShamir Geller, Haoming Xu, Mark Lebwohl, et al.
Nutrition and Cancer|April 17, 2004
Protective effects of lycopene against ultraviolet B-induced photodamageZsuzsanna Fazekas, Dayuan Gao, Rao N Saladi, et al.
JAMA Dermatology|February 15, 2013
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligoPearl E Grimes, Iltefat Hamzavi, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|July 27, 2025
Healthcare resource utilization and economic burden in generalized pustular psoriasis (GPP) among U.S. adults: A large claims database analysisMark Lebwohl, Bhargav Lakshminarasimhan, Layla Lavasani, et al.
Skinmed|May 23, 2017
Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled StudiesAlan Menter, Linda Stein Gold, John Koo, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment|April 26, 2021
Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasisMark Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Cutis|March 22, 2011
Necrolytic migratory erythema associated with a metastatic neuroendocrine tumorMargarita S Lolis, Anna Krishtul, Claudia Vidal, et al.
Journal of the American Academy of Dermatology|December 31, 2005
The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasisAlan Menter, Jennifer C Cather, Diane Baker, et al.
Pageof 42